(Q30914643)

27 June 2017

1 reference

title

The use of phage display for the development of tumour targeting agents (English)

1 reference

27 June 2017

1 reference

Nilsson F

1

1 reference

27 June 2017

Tarli L

series ordinal

2

1 reference

27 June 2017

Viti F

series ordinal

3

1 reference

27 June 2017

Neri D

series ordinal

4

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Advanced Drug Delivery Reviews

27 June 2017

published in

1 reference

27 June 2017

volume

43

1 reference

27 June 2017

issue

2-3

1 reference

27 June 2017

page(s)

165-196

1 reference

Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

The promise and pitfalls of monoclonal antibody therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Intralesional radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Prevention of manifest metastasis with monoclonal antibodies: A novel approach to immunotherapy of solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Assembly of a functional immunoglobulin Fv fragment in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Escherichia coli secretion of an active chimeric antibody fragment.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

High level Escherichia coli expression and production of a bivalent humanized antibody fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Affinity reagents against tumour-associated extracellular molecules and newforming vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Localization of monoclonal antibody TNT-1 in experimental kidney infarction of the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Biodistribution in tumour-bearing mice of polycationic, amphoteric and polyanionic branched polypeptides with a poly(L-lysine) backbone labelled with 125I and 111In: tumour accumulation less than that of labelled serum proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Surface presentation of protein epitopes using bacteriophage expression systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Phage antibodies: filamentous phage displaying antibody variable domains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Selecting high-affinity binding proteins by monovalent phage display

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Antibody-selectable filamentous fd phage vectors: affinity purification of target genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Surface expression and ligand-based selection of cDNAs fused to filamentous phage gene VI.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Modifying filamentous phage capsid: limits in the size of the major capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Hormone phage: an enrichment method for variant proteins with altered binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Fab assembly and enrichment in a monovalent phage display system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Proteolytic selection for protein folding using filamentous bacteriophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Selecting proteins with improved stability by a phage-based method

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage 1 1Edited by J. Karn

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A method for directed evolution and functional cloning of enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Prostate cancer and prostate bed SPECT imaging with ProstaScint: semiquantitative correlation with prostatic biopsy results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

The clinical significance of HAMA in patients treated with mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Production and selection of antigen-specific fully human monoclonal antibodies from mice engineered with human Ig loci

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Strategies for expressing human antibody repertoires in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Antigen-specific human antibodies from mice comprising four distinct genetic modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Beta-turn propensities as paradigms for the analysis of structural motifs to engineer protein stability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Antibody engineering: advances from the use of Escherichia coli expression systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Antibody scFv fragments without disulfide bonds made by molecular evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Single-chain antigen-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

High-level secretion of two antibody single chain Fv fragments by Pichia pastoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Production of monoclonal antibodies in COS and CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Manipulation of baculovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Biophysical methods for the determination of antibody-antigen affinities

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A comparison of strategies to stabilize immunoglobulin Fv-fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Making antibody fragments using phage display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Patch engineering: a general approach for creating proteins that have new binding activities

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Antibody VH domains as small recognition units

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Human anti-self antibodies with high specificity from phage display libraries.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Triabodies: single chain Fv fragments without a linker form trivalent trimers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [gamma-32P]-ATP.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Engineering bispecific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

High-affinity antigen binding by chelating recombinant antibodies (CRAbs).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastoris

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A recombinant immunotoxin containing a disulfide-stabilized Fv fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

New protein engineering approaches to multivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Mammalian cell expression of dimeric small immune proteins (SIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Creating and engineering human antibodies for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Mix and match: building manifold binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Naturally occurring antibodies devoid of light chains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Potent enzyme inhibitors derived from dromedary heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A designed metal-binding protein with a novel fold

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Coupling protein design and in vitro selection strategies: improving specificity and affinity of a designed beta-protein IL-6 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Synthetic human antibodies and a strategy for protein engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Phage libraries for generation of clinically useful antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Monoclonal antibodies in cancer detection and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Designing and optimizing library selection strategies for generating high-affinity antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Large-scale immunohistological staining using polyethylene glycol-embedded sections mounted on 96-well plates for monoclonal antibody screening

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Exploiting recombination in single bacteria to make large phage antibody libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

An efficient route to human bispecific IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Generation of a panel of related human scFv antibodies with high affinities for human CEA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Site-directed antibodies to vertebrate and plant calmodulins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

The Imprint of Somatic Hypermutation on the Repertoire of Human Germline V Genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Preparation of phage antibodies to the ED-A domain of human fibronectin.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Selection of an anti-IGF-1 Fab from a Fab phage library created by mutagenesis of multiple CDR loops

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Domain libraries: Synthetic diversity for de novo design of antibody V-regions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Construction of a semisynthetic antibody library using trinucleotide oligos

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Towards the design of an antibody that recognises a given protein epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Synthesis of Rh Fv phage-antibodies using VH and VL germline genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Comparison of fusion phage libraries displaying VH or single-chain Fv antibody fragments derived from the antibody repertoire of a vaccinated melanoma patient as a source of melanoma-specific targeting molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Design and use of phage display libraries for the selection of antibodies and enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Selection of phage antibodies by binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A model system for detection and isolation of a tumor cell surface antigen using antibody phage display

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

A model phage display subtraction method with potential for analysis of differential gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Phage antibodies against human dendritic cell subpopulations obtained by flow cytometry-based selection on freshly isolated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Model systems to study the parameters determining the success of phage antibody selections on complex antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Targeted gene delivery to mammalian cells by filamentous bacteriophage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Biodistribution of filamentous phage-Fab in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Improving antibody affinity by mimicking somatic hypermutation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Rapid detection of recombinant antibody fragments directed against cell-surface antigens by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Directed selection of MIP-1 alpha neutralizing CCR5 antibodies from a phage display human antibody library.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Organ targeting in vivo using phage display peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

The use of biosensor technology for the engineering of antibodies and enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Yttrium-90-labelled somatostatin-analogue for cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Construction and evolution of antibody-phage libraries by DNA shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Identification of functional and structural amino-acid residues by parsimonious mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Redirection of cellular cytotoxicity. A two-step approach using recombinant single-chain Fv molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Efficient one-step direct labelling of recombinant antibodies with technetium-99m

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Metal-binding chimeric antibodies expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Transmittance of nonionizing radiation in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Immunotoxins for targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Tumor protease-activated, pore-forming toxins from a combinatorial library.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Immunocytokines: a promising approach to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Bispecific antibodies: the new magic bullets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Use of photosensitive, antibody directed liposomes to destroy target populations of cells in bone marrow: a potential purging method for autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Tyrosine kinase chimeras for antigen-selective T-body therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Retroviral vectors displaying functional antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Somatostatin receptor imaging in intracranial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

In vitro selection from protein and peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Searching for Peptide Ligands with an Epitope Library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Peptides on phage: a vast library of peptides for identifying ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Random peptide libraries: a source of specific protein binding molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Filamentous phage display of oligopeptide libraries.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Identification of biologically active peptides using random libraries displayed on phage.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Substrate phage: selection of protease substrates by monovalent phage display

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Small peptides as potent mimetics of the protein hormone erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

"Peptabody": a new type of high avidity binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Increased potency of an erythropoietin peptide mimetic through covalent dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Tendamistat as a scaffold for conformationally constrained phage peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Alternate protein frameworks for molecular recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

[7] The use of carbodiimides in the preparation of immunizing conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Biosynthetically lipid-modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Uranium-loaded apoferritin with antibodies attached: molecular design for uranium neutron-capture therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Efficient epitope mapping by bacteriophage lambda surface display

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Display of peptides and proteins on the surface of bacteriophage lambda

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Surface display of proteins on bacteriophage lambda heads

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Lambda foo: a lambda phage vector for the expression of foreign proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Immobilizing proteins on the surface of yeast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

An in vitro polysome display system for identifying ligands from very large peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

In vitro selection and evolution of functional proteins by using ribosome display

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

DNA recombination. Four pins for four petals.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Conflicts brewing as phage display gets complex

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

Combinatorial cassette mutagenesis as a probe of the informational content of protein sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900068-5

7 January 2021

10.1016/S0169-409X(00)00068-5

Identifiers

DOI

1 reference

27 June 2017

1 reference